Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPOS and Corifollitropin alfa cross-over in elective freeze-all cycles
2023-506694-35-00Phase 4Authorised
- Sponsor
- Ghent University Hospital
- Start
- Oct 2023
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of corifollitropin alfa and desogestrel in hypofertility (2 arms), sponsored by Ghent University Hospital. Primary endpoint: Treatment-related quality of life and patient satisfaction (Q2). Planned start Oct 2023; status: authorised.
02
Drugs
corifollitropin alfadesogestrel
03
Conditions
hypofertility
Beyond the preview
Go deeper on 2023-506694-35-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-506694-35-00.